DONNA BAKER: Open Payments
NPI 1790353209 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 17 payments from 9 companies in 2025. Trend: 2023 $573 · 2024 $563 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $195 |
| Novo Nordisk Inc | 3 | $57 |
| Amgen Inc. | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: AIRSUPRA, Ozempic, BREZTRI, REPATHA, Kerendia, VRAYLAR, JARDIANCE, Rybelsus.
Industry payments across MD — which companies pay providers there.
